FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
UnitedHealth Group (NYSE:UNH), long regarded as a stable investment, shocked Wall Street by missing earnings estimates for the first time since 2008. Shares of the largest U.S. health insurer tumbled over 22% Thursday, wiping out nearly $120 billion in market value—its worst single-day drop in more than 25 years.
The company reported Q1 revenue of $109.6 billion, falling about $2 billion short of analyst expectations. Earnings also missed forecasts, primarily due to rising medical costs in its Medicare Advantage plans and unexpected disruptions within Optum, its health services and pharmacy benefits division once seen as a key growth engine.
While executives offered some transparency during the earnings call, analysts were left with unanswered questions. “We do not believe the earnings call answered all investors’ questions,” said Mizuho’s Ann Hynes, noting UnitedHealth’s typically conservative and upward-trending guidance history.
Initially, investors feared a broader industry issue, triggering sell-offs across health insurers. However, the panic eased after Elevance Health (NYSE:ELV) reaffirmed its quarterly guidance, helping its stock rebound from an early 5.8% drop to end down just 2.3%. UnitedHealth, however, saw no such recovery.
The earnings disappointment adds to a turbulent year for UnitedHealth, which included a cyberattack impacting 200 million Americans and the high-profile murder of insurance unit head Brian Thompson. Additionally, the Department of Justice is reportedly investigating its Medicare billing practices, though the company denies knowledge of an active probe.
Concerns also mounted over Optum’s declining performance, especially following changes in 2025 Medicare reimbursements. “Optum was always the silver lining,” said Bahl & Gaynor’s Kevin Gade, expressing surprise at its underperformance.
Investors now await updates from rivals like Humana (NYSE:HUM), whose shares also dropped 7%, to assess the broader implications for the Medicare Advantage market.
